Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.
Amrutanjan Health Care financials and key ratios
Figures from the company's filings with NSE
In FY26 its consolidated net profit was ₹57.9 crore on revenue of ₹503 crore. It had no borrowings on 31 March 2026. Promoters held 46.52% of the shares on 30 September 2026.
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026
Amrutanjan Health Care at a glance · consolidated
ROE (FY26)
16.6%+0.1 pts vs FY25ROCE 19.3%
Debt to equity
0.00net cash ₹36.4 Cr
Promoter holding
46.52%unchanged vs 30 Jun 202630 September 2026
Net worth
₹370 Cr31 March 2026
Free cash flow (FY26)
−₹19 Cr
EPS (FY26)
₹20.03
Questions
Is Amrutanjan Health Care debt free?
Yes. Amrutanjan Health Care had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹36.4 crore of cash, bank balances and current investments.
What is the Amrutanjan Health Care debt to equity ratio?
Amrutanjan Health Care's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹370 crore.
What is the Amrutanjan Health Care net worth?
Amrutanjan Health Care's net worth — shareholders' equity in its consolidated balance sheet — was ₹370 crore on 31 March 2026.
What is the Amrutanjan Health Care ROE and ROCE?
In FY26, Amrutanjan Health Care's return on equity (ROE) was 16.6% and its return on capital employed (ROCE) was 19.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 16.5% and ROCE 16.3%.
What is the Amrutanjan Health Care shareholding pattern?
On 30 September 2026, Amrutanjan Health Care's shares were held by promoters 46.52%, foreign portfolio investors (FII/FPI) 3.47%, domestic institutions (DII) 6.90% (including mutual funds at 3.60%) and retail and other non-institutional investors 43.08%. Over the year, FII holding was up 1.09 percentage points from 2.38% and DII holding was down 6.00 percentage points from 12.90%.
What is the Amrutanjan Health Care free cash flow?
In FY26, Amrutanjan Health Care generated ₹36 crore of cash from operations and spent ₹55 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹19 crore. In FY25 it was ₹15.3 crore.
What is the Amrutanjan Health Care book value per share?
Amrutanjan Health Care's book value per share was ₹128.06 on 31 March 2026: shareholders' equity of ₹370 crore divided by the 2.89 crore shares in issue.
What is the Amrutanjan Health Care dividend in 2026 and its record date?
In 2026, Amrutanjan Health Care has declared two dividends totalling ₹3.90 a share: ₹1 (interim) with record date 7 February 2026 and ex-date 6 February 2026 and ₹2.90 with record date 11 September 2026.
What is the Amrutanjan Health Care promoter holding?
Promoters held 46.52% of Amrutanjan Health Care on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What is the Amrutanjan Health Care EPS?
Amrutanjan Health Care's basic earnings per share (EPS) were ₹20.03 in FY26, against ₹17.58 in FY25.
What is the Amrutanjan Health Care revenue and profit in FY26?
In FY26 (April 2025–March 2026), Amrutanjan Health Care's consolidated net profit was ₹57.9 crore, up 13.9% from ₹50.8 crore in FY25, on revenue from operations of ₹503 crore (up 11.2%). Over three years, from FY23, net profit was up 45.4%.
Where do these Amrutanjan Health Care figures come from?
From Amrutanjan Health Care's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
